ACTA1 and LADD syndrome: Attenuated strains of Lm such as LADD, which is deficient for the virulence factors actA and inlB69 are currently utilized in multiple clinical trials56 and an engineered LADD strain expressing two MC38 neo-epitopes was shown to increase CD8 T cell infiltration into the tumor58.